Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.55% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1451
Genco Shipping & Trading
GNK
$1.19B
| $55M | 0.01% |
2,441,126
-18,684
| -0.8% | -$400K |
2016 Q4
37 quarters
|
|
1452
HCI Group
HCI
$2.26B
| $54.9M | 0.01% |
354,884
+36,348
| +11% | +$5.95M |
2013 Q2
51 quarters
|
|
|
RAL
1453
Ralliant Corp
RAL
$7.83B
| $54.7M | 0.01% |
1,314,834
+496,171
| +61% | +$23.3M |
2025 Q2
3 quarters
|
|
1454
Amalgamated Financial
AMAL
$1.43B
| $54.6M | 0.01% |
1,404,730
-4,981
| -0.4% | -$189K |
2021 Q2
19 quarters
|
|
1455
ScottsMiracle-Gro
SMG
$2.91B
| $54.5M | 0.01% |
895,841
+72,179
| +9% | +$4.67M |
2013 Q2
51 quarters
|
|
1456
Power Integrations
POWI
$2.88B
| $54.1M | 0.01% |
1,057,155
+71,928
| +7% | +$3.3M |
2013 Q2
51 quarters
|
|
1457
Freshpet
FRPT
$2.77B
| $54.1M | 0.01% |
917,785
+78,196
| +9% | +$5.49M |
2019 Q4
25 quarters
|
|
|
PLGO
1458
Pelagos Insurance Capital
PLGO
$2.01B
| $53.9M | 0.01% |
2,823,089
+35,955
| +1% | +$688K |
2024 Q3
6 quarters
|
|
1459
Ceco Environmental
CECO
$4.21B
| $53.8M | 0.01% |
903,291
+7,751
| +0.9% | +$499K |
2013 Q2
51 quarters
|
|
|
APLS
1460
DELISTED
Apellis Pharmaceuticals
APLS
| $53.7M | 0.01% |
1,338,995
+1,158,070
| +640% | +$25M |
2025 Q3
2 quarters
|
|
1461
OneSpaWorld
OSW
$2.31B
| $53.6M | 0.01% |
2,335,346
+27,309
| +1% | +$581K |
2020 Q4
21 quarters
|
|
|
SUNC
1462
SunocoCorp LLC
SUNC
$3.9B
| $53.6M | 0.01% |
869,068
-196
| -0% | -$11.1K |
2025 Q4
1 quarter
|
|
1463
NWPX Infrastructure Inc
NWPX
$1.01B
| $53.6M | 0.01% |
688,119
-3,905
| -0.6% | -$282K |
2013 Q2
51 quarters
|
|
1464
Protagonist Therapeutics
PTGX
$9.01B
| $53.5M | 0.01% |
508,103
+93,688
| +23% | +$8.3M |
2018 Q2
31 quarters
|
|
1465
Tronox
TROX
$610M
| $53.3M | 0.01% |
5,457,105
-1,099,073
| -17% | -$7.62M |
2013 Q2
51 quarters
|
|
1466
National Beverage
FIZZ
$2.78B
| $53.3M | 0.01% |
1,582,865
+138,433
| +10% | +$4.8M |
2013 Q2
51 quarters
|
|
1467
MGE Energy Inc
MGEE
$2.65B
| $52.9M | 0.01% |
684,267
-3,042
| -0.4% | -$240K |
2013 Q2
51 quarters
|
|
1468
WisdomTree
WT
$3.64B
| $52.8M | 0.01% |
3,624,396
-17,646
| -0.5% | -$273K |
2013 Q2
51 quarters
|
|
1469
Live Oak Bancshares
LOB
$1.68B
| $52.7M | 0.01% |
1,593,185
+54,750
| +4% | +$2.02M |
2017 Q2
35 quarters
|
|
1470
Preferred Bank
PFBC
$1.26B
| $52.5M | 0.01% |
579,154
-7,195
| -1% | -$652K |
2013 Q2
51 quarters
|
|
1471
California Water Service
CWT
$2.79B
| $52.5M | 0.01% |
1,158,359
+4,428
| +0.4% | +$199K |
2013 Q2
51 quarters
|
|
1472
FIGS
FIGS
$2.34B
| $52.5M | 0.01% |
3,552,919
+257,644
| +8% | +$3.3M |
2022 Q3
14 quarters
|
|
1473
Navient
NAVI
$854M
| $52.2M | 0.01% |
6,383,533
-957,534
| -13% | -$9.48M |
2014 Q2
47 quarters
|
|
1474
MillerKnoll
MLKN
$1.39B
| $52.2M | 0.01% |
3,610,776
+103,372
| +3% | +$2.03M |
2013 Q2
51 quarters
|
|
|
DOCU
1475
DocuSign
DOCU
$13B
| $52.2M | 0.01% |
1,100,891
+80,442
| +8% | +$4.12M |
2019 Q1
28 quarters
|
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.